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Abstract
Genome editing is revolutionising the field of genetics, which includes novel appli-
cations to food animals. Responsible research and innovation (RRI) has been advo-
cated as a way of ensuring that a wider-range of stakeholders and publics are able 
to engage with new and emerging technologies to inform decision making from 
their perspectives and values. We posit that genome editing is now proceeding at 
such a fast rate, and in so many different directions, such as to overwhelm attempts 
to achieving a more reflective pace. An alternative location for reflection is dur-
ing the much slower process of taking products from the lab to market. We suggest 
emphasising Responsible Innovation, putting the ‘I’ back into RRI, and encourag-
ing companies to embrace an RRI approach. We review some previous attempts at 
developing industry-relevant frameworks for RRI. We then describe two examples 
of genome editing in livestock; hornless cattle and disease resistant pigs, and reflect 
on the sorts of questions that could be considered in these two genome editing 
examples. This paper seeks to take forward the discussion on RRI by extending it to 
bringing products to market in the context of genome edited livestock.
Keywords Responsible research and innovation · Genome editing · Gene editing · 
Livestock · Agriculture · Public engagement
Introduction
Genome editing is an emerging technology which has revolutionised the field of 
genetics, by providing a far more precise, rapid and cheap way for humans to mod-
ify, adapt and use animals, plants and lower organisms, and even to alter their own 
genome. But the very rapidity of its uptake and the breadth of its scope present a 
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serious policy challenge to the prevailing model of responsible research and innova-
tion (RRI). RRI has been described by the European Commission as “an approach 
that anticipates and assesses potential implications and societal expectations with 
regard to research and innovation, with the aim to foster the design of inclusive and 
sustainable research and innovation”. It has come to represent a greater emphasis 
on upstream, stakeholder and public engagement on novel technologies, in the wake 
of the 1999 genetically modified food crisis. But the very speed and breadth of the 
scientific development of genome editing presents a context in which appropriate 
public understanding and ethical reflection of the technology become difficult.
In this paper we explore the tensions between responsible innovation and devel-
opments in genome editing applied to livestock animal applications for food. This 
field had largely lain outwith the scope of earlier genetic modification techniques, 
but has emerged as a likely early commercial uptake of genome editing. It is timely 
to consider these questions because the range of potential applications of genome 
editing is growing rapidly, and some are at an advanced stage of development.
Decisions made about the governance of genome editing at this early stage are 
likely to have major impacts on future developments. Such decisions have the poten-
tial either to ‘strangle at birth’ ideas that in retrospect prove to have been important, 
or on the other hand to enable applications which are later regretted, often due to 
adverse unintended consequences. Thus it is important to explore how a responsible 
innovation pathway can be navigated through these challenges.
This paper is drawn from and informed by our long-standing experience in the 
ethical and social dimensions of the application of genetics to agriculture, and our 
engagement with both research and industrial contexts and with experts, stake-
holders and publics, beginning in 1993 with one of the first studies on the ethics of 
genetic engineering technologies to micro-organisms, plants and animals (Bruce and 
Bruce 1998), through to ongoing current research on genome editing ethics. One of 
us (Bruce, A.) researches in innovation studies in agriculture, including public and 
stakeholder discussions, and formerly worked in commercial pig genetics. The other 
(Bruce, D.) has performed extensive ethical studies over 25 years in biotechnology 
and nanotechnology, and developed tools for public engagement in several of these 
fields. While we reflect a primarily UK perspective on the questions, this is set in the 
wider European discussions on the role of responsible research and innovation, and 
of the current and historic influence that the European Union (EU) policies have had 
on the UK.
The paper is structured as follows. First we reflect on what is understood by 
responsible research and innovation in the impetus to make science more democratic 
and accountable, and in the wake of adverse public reactions to Genetically Modi-
fied (GM) crops. We then consider the developments in genome editing, in particu-
lar following the introduction of CRISPR-Cas9 technology, and highlight two poten-
tially near-market applications in dairy cattle and pigs. We assess the challenge to 
RRI that rapid expansion and enormous scope of genome editing at the research 
stage presents, the potential of RRI in the much slower process of bringing an inno-
vation to market, and the neglected application of RRI to industry. Finally, we return 
to the two genome editing examples and reflect on the sorts of issues which an RRI 
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approach would need to consider in relation to these innovations to relate them to 
wider society, and on the importance that such a process is indeed performed.
About RRI
Responsible research and innovation (RRI) emerged as a concept in the early 2000s, 
as a response by the European Commission (EC) to the governance challenges 
first posed to regulation by GM crops, of needing to relate new scientific develop-
ments, such as embryonic stem cells, nanotechnologies, synthetic biology and geo-
engineering, to society. It may be seen as a way to articulate and apply the notion 
that technological innovation should not just be the activity of the principal play-
ers of science, industry and government, with the general public merely in the role 
of recipient consumers, whose only engagement is whether they do or do not buy 
the resulting products. The RRI concept sets out that publics should be given the 
opportunity to engage and interact with the proposed innovations as citizens in a col-
laborative exercise of decision making. It embodies the assumption that there may 
be valid values, concerns and insights, when seen from other perspectives than just 
those of the promoters of a technology, and which need to be given due considera-
tion in policy making. A focal implication of RRI is that, if it can be articulated suf-
ficiently cogently, the ‘wisdom’ of the wider culture should have at least some power 
to change what ‘the usual players’ would otherwise have done with their innovation, 
if left to their own devices.
The notion of responsibility in innovation can be traced far back in the history 
of technology (Mitcham and von Schomberg 2000), moving from the individual 
engineer to wider society. In some ways RRI can be seen as a development of an 
approach that became especially associated with the Human Genome Project, in 
which Ethical, Legal and Social Issues (ELSI) were addressed at an expert profes-
sional level in parallel with the science (Knoppers et  al. 2013). RRI tends to set 
a less dominant role for expert ethical reflection, and places greater emphasis on 
lay public and stakeholder engagement and its analysis by social science methods. 
Ribeiro observes that RRI could be viewed as “the latest manifestation in a long 
line of policy-oriented debates concerned with providing space to consider and 
debate the interactions between the oft-separated worlds of ‘science’ and ‘society’” 
(Ribeiro et al. 2017: 84).
RRI is a multi-dimensional concept which can be described in many ways. Von 
Schomberg summarises it as “RRI should be understood as a strategy of stakehold-
ers to become mutually responsive to each other and anticipate research and innova-
tion outcomes underpinning the ‘grand challenges’ of our time for which they share 
responsibility”, which implies “broader foresight and impact assessments for new 
technologies beyond their anticipated market-benefits and risks.” (von Schomb-
erg 2013). RRI reflects variously the desire to avoid unintended consequences, to 
align innovation to societal expectations and to democratise science by opening it 
up to wider debate, particularly when science challenges basic values (Ribeiro et al. 
2017).
 A. Bruce, D. Bruce 
1 3
The approach was adopted by the EC both as a key action and a cross-cutting 
issue in the Horizon 2020 research programme, with the expectation that “societal 
actors (researchers, citizens, policy makers, business, third sector organisations etc.) 
work together during the whole research and innovation process in order to better 
align both the process and its outcomes with the values, needs and expectations of 
society”.1
The UK Engineering and Physical Sciences Research Council (EPSRC) has for-
malised the approach into a framework for Responsible Innovation that “seeks to 
promote creativity and opportunities for science and innovation that are socially 
desirable and undertaken in the public interest”. Furthermore “Responsible innova-
tion creates spaces and processes to explore these aspects of innovation in an open, 
inclusive and timely way”2 (our emphasis).
The EPSRC’s framework, for example, advocates an approach that encompasses 
anticipation, reflection, engagement and action, as follows. Anticipation involves 
describing and analysing impacts (intended or otherwise). Reflection requires think-
ing about the purposes, motivation, uncertainties, ignorance, assumptions, framings 
and social transformations entailed. Engagement involves opening up visions for 
broader deliberation. Finally, Action uses the above processes to influence decisions. 
The EPSRC also acknowledges that no single approach is appropriate for all appli-
cations, and therefore requires researchers to have demonstrated their awareness and 
commitment to these key steps, in ways appropriate to their activity.
These four criteria in EPSRC’s framework broadly echo four core dimensions 
(anticipation, reflexivity, inclusion and responsiveness) that are identified widely in 
literature (e.g. Stilgoe et al. 2013; Burget et al. 2017). Several other dimensions are 
also noted, namely transparency (Pellé 2016), trust (Asveld et al. 2015), sustainabil-
ity and care (Burget et al. 2017). The term ‘Care’ is used here as a way of capturing 
the need to take responsibility for the effects of technological developments. RRI 
thus seeks to bring together ideas found variously in technology assessment, ELSI 
and public engagement.
Another feature of RRI in some understandings is in providing socially desirable 
innovations. In this approach, some advocate switching the typical presentation of 
an innovation as a solution to a problem to asking first what is the problem, and 
then considering all the different ways of approaching answering it, including the 
proposed novel technology. In practice, matters may be more complex. A problem 
may have reached stalemate, and is only highlighted again when an innovator spots 
an opportunity to apply their technology to it. The question then needs to be asked 
if this is indeed the best solution to the problem. It is thus a more iterative process, 
looking from both sides, which is indeed a role for RRI.
At the same time as advocating an RRI approach, the UK Government and EU 
both strongly emphasise the role of science for the purpose of economic growth and 
the generation of employment opportunities. The relationship between research and 
1 https ://ec.europ a.eu/progr ammes /horiz on202 0/en/h2020 -secti on/respo nsibl e-resea rch-innov ation 
accessed 24/11/18.
2 https ://epsrc .ukri.org/index .cfm/resea rch/frame work/acces sed 2/5/18.
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industrial application is considered very important. Tait, however, notes that RRI 
has tended to focus more on responsible research than responsible innovation (Tait 
2017). Given that an impetus for RRI was the societal resistance to genetically mod-
ified organisms (GMOs) in the EU, and that at least part of the resistance was the 
dominance of multinational companies in the production of GMOs, it would be of 
concern if RRI was failing to address the critical industrial and commercial context 
by which innovations come to market.
Here the context for RRI is different. The competitive element of commercial 
enterprise is not to be first to publish but to establish a market, often over their com-
petitors’ rival products, and to maintain share price and reputation. New spin-out 
companies from academic establishments are particularly vulnerable, often strug-
gling to maintain funding streams until they place their product on the market that 
is able to maintain the existence of the company though income gained from sales. 
The need to bridge this gap between research funding and commercial income (often 
referred to as the ‘valley of death’) means there is an urgency to getting products 
onto the market. The relation of these factors to RRI is discussed further in “Putting 
the ‘I’ Back into RRI” section.
Genome Editing in Livestock Animals
Genome editing has emerged following the development of a set of powerful sci-
entific tools potentially capable of making a wide range of changes in the DNA of 
plants, animals and perhaps even human embryos. In particular, the development of 
the CRISPR-Cas9 technique has provided a cheap, easy to perform and remarkably 
precise technique to cut the DNA at a chosen location, and then to delete, replace 
or insert specific genetic material. Whereas the genetic modification methods pio-
neered in the 1980s and 1990s tended to perform random insertions, from which 
the desired ones were selected, CRISPR and its related genome editing techniques 
achieve something like the precision which was claimed for GM, but not really 
delivered.
The introduction of genome editing tools in the early 2000s has transformed the 
prospects for manipulating DNA. A suite of tools, including Zinc Finger Nucleases, 
Transcription Activator-like effector nucleases (TALENS) and, most recently Clus-
tered Regularly Interspaced Short Palidromic Repeats (CRISPR) offer the promise 
of precision cutting of DNA with enzymes (some of which, such as CRISPR are part 
of the natural immune defence mechanism of bacteria). They can introduce changes 
either by spontaneous mutation due to inaccuracies in the resulting DNA repair, or 
more precisely, by providing a donor template to introduce the desired change (e.g. 
Ruan et al. 2017). While gene variants present in other species may be introduced 
(the introduction of so-called transgenes), the technique also allows modification of 
single nucleotides, representing variants present in another breed of the same spe-
cies (e.g. Carlson et al. 2016). This relative ease of use of CRISPR has opened up 
multiple opportunities in a wide-range of applications for use of this technology.
The precision of genome editing has been challenged on the basis of the existence 
of off-site effects, where changes in the DNA occur in places other than the area 
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targeted. These effects continue to stimulate debate and their importance remains 
controversial. Some advocate that they cannot be completely eliminated, yet others 
suggest they only rarely occur, and techniques for reducing their incidence or for 
removing them have been mooted.
To date, genome editing has been applied at an experimental level to several live-
stock species in a number of different applications. Examples are increased resist-
ance to cattle diseases (e.g. Wu et al. 2015), producing more muscle in otherwise 
very un-muscled varieties of cattle and sheep (e.g. Proudfoot et al. 2015), and eggs 
with reduced allergenicity (COGEM 2017; Hoyos-Flight et al. 2017 quoting work by 
Tim Doran). In this paper, we consider the two most advanced applications, namely 
the production of dairy cows which do not develop horns, known as polled cows 
(Carlson et al. 2016), and pigs resistant to a serious but common disease, Porcine 
Reproductive and Respiratory Syndrome (PRRS) (Whitworth et al. 2016; Burkard 
et al. 2017).
In the first of these, the presence or absence of horns is controlled by variations 
or mutations in a single gene, although the exact nature of the variation can dif-
fer among breeds. Polled dairy cows do exist, but they are rare. However, polled 
variants exist more commonly in other cattle breeds, such as Aberdeen Angus. In 
the example reported by Carlson et al. (2016), genome editing techniques have been 
used to introduce a gene variant from Aberdeen Angus into a Holstein dairy breed of 
cow, resulting in a polled dairy cow (see also Eriksson et al. 2018).
It is argued that genome editing will allow the introduction of the desired charac-
teristic directly into elite dairy cows, rapidly and without losing any other desirable 
characteristics. Mulder has estimated that using genome editing the polled charac-
teristic could be made predominant in dairy cattle within 2–5 generations (COGEM 
2017) whereas it could take 20–30 years to do so by traditional means (Bastiaansen 
et al. 2018). The stated motivation is to benefit both animal and human welfare.
The second example is to use genome editing in pigs to induce resistance to Por-
cine Reproductive and Respiratory Syndrome (PRRS). PRRS is a widely occurring 
pig disease around the world, causing reproductive losses and deaths of young pig-
lets. From an economic point of view, PRRS can cause serious economic damage to 
an industry that at times is working with small margins between profit and loss. It 
affects both pigs kept indoors and those kept outdoors. The virus exists in different 
strains. The US has a more serious strain than in Europe. In the UK, PRRS infection 
can be controlled to some extent by vaccination, however the process of vaccination 
does require handling and injecting the pigs and it can be costly.
Two versions of genome editing to produce resistance to PRRS in pigs have been 
reported in the scientific literature. The first report (Whitworth et al. 2016) produced 
a complete removal of the gene CD163, whereas the second (Burkard et al. 2017) 
has only removed a portion of the gene that is required for infection. A question 
remains as to what are the functions of this gene other than its effect on disease. 
Removing only a part of the gene is less likely to affect other aspects of the pig’s 
physiology than removing the whole gene.3 Both developments have been made in 
3 Bruce Whitelaw, personal communication.
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collaboration with a major international pig breeding company (Genus plc) which 
now seeks to take the products through the FDA regulatory system, with a view to 
having products in the market within a few years (Genus 2015).
We highlight these as examples of considerable scientific and increasing com-
mercial interest in using genome editing as a way of altering the genetic make-up of 
livestock. We note also that much of the emphasis has been on welfare issues which 
affect production, rather than purely improving productivity.
Genome Editing as a Challenge to Responsible Research 
and Innovation
From a scientific point of view, genome editing is a very exciting innovation, whose 
apparently boundless prospects have activated scientists all over the world in many 
different fields to apply the techniques to areas both old and new. Its development 
has become not the disciplined flow of a limited number of research groups, but 
rather an avalanche of applications, spreading rapidly and chaotically. A search in 
Web of Science found 139 papers referring to CRISPR in 2010–2011, increasing to 
5809 in 2016–2017. In that time period, the number referring to a livestock species 
increased from two to around 140, although not all referring to agricultural applica-
tions. It is hard even for specialists and policy makers to keep pace with develop-
ments, some of which may have far-reaching social and ethical implications. How 
then can wider society make any meaningful engagement or have a say in something 
that is happening so fast within the confines of the scientific community, with which 
it is not normally engaged? We suggest that the speed, the breadth of scope and the 
disruptive potential of genome editing together present a serious challenge to the 
very concept of socially responsible research and innovation.
In such a rapidly moving and novel scientific field, the predominant values are apt 
to be those underlying innovation and curiosity, and the drive to be first in the field, 
in preference to wider ethical, social and environmental considerations. The pres-
sure on time to be the first to publish, to patent, or to market operates in opposition 
to the idea of a relaxed timescale sufficient for wider society to evaluate develop-
ments and express a view about them.
A responsible scientist may have given much thought to the implications of his 
or her work, and will have lived with it for some considerable time. To other stake-
holders and the wider public, however, it may be a completely novel and surpris-
ing idea, which they need to take time to assimilate, understand and evaluate. For a 
development to be considered responsibly by wider publics, it is not simply a matter 
of informing the public and then inserting a quick ‘ethics’ step in the process of for-
warding the innovation. Even once people have had the opportunity to learn about 
the piece of work, ethical reflection on an unfamiliar and perhaps challenging topic 
inevitably takes much longer.
A single exercise in ‘public engagement’ is not sufficient. At best this can only 
represent a lay person’s short-term response to the novel field. It can take a much 
longer time to consider the merits or otherwise of a disruptive idea against one’s 
personal set of values and view of the world. If the people engaged continue to 
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reflect upon it over the next few months, their views will mature and may change. 
Studies engaging publics should seek to return to the participants perhaps a year 
after the main engagement, and ask them how their views have developed, and what 
they think about what has happened in the field in the intervening 12 months.
Moreover, most public engagement exercises will involve, at best, a few hundred 
people out of a population of millions, leaving wider society so far unengaged. Only 
once the media or social media pick up an issue does a much wider constituency of 
people normally begin to think about it. This has the advantage of wider discussion, 
but carries the disadvantage that, instead of a carefully planned and informed delib-
erative exercise, the topic is then framed by what the media think ‘makes a good 
story’. This is often accompanied by ‘sound bytes’, or journalistic tropes, which may 
deflect the issue on to simplistic or unhelpful ways of thinking, or occasionally even 
false concepts, such as the connotations engendered in the public mind by the repeti-
tion of the slogan ‘Frankenstein foods’ in the GM food debate.
Prominent among the media tropes are an adversarial two-way conflict, and the 
need to present both sides of the argument with apparent equal weight, which may 
mislead if the argument is multi-dimensional or if a minority scientific view is given 
an apparent weight far in excess of its validity and support. A newspaper may take 
a stance of aggressively promoting one side of the case, and ‘spin’ their reportage 
to suit their current editorial policy. Thus the citizen’s deliberation is apt to be con-
fused by what is reported of the conflicting claims and disputed evidence of the 
major stakeholders, without having the background to weigh up the claims. In social 
media, importance may be given to a particular person whose comments and opin-
ions one ‘follows’ but whose knowledge and experience of the subject may be only 
limited and, in reality, unable to bear the weight of trust put upon them. Someone 
may be trusted by not trustworthy (O’Neill 2018).
If left to a media process alone, the risk is that, heard through the lens of a polar-
ised framing of the issues, publics may simply reject an innovation if it appears too 
disruptive or uncertain, when they might have reacted differently if it had proceeded 
at a pace sufficient to allow public deliberation. One hope of RRI is that upstream 
engagement would provide such a process of deliberation to happen. However, no 
effective process has yet been found to disseminate small scale exercises, such as 
citizen’s juries, to the population at large, especially when the issue may not loom 
large in a given person’s matters of current concern.
A further question is, when is the right time to engage with publics about a novel 
scientific development. In the case of genetically modified crops it was far too late, 
but it can also be too early. Public engagement needs to be grounded in what is 
realistically possible, and what are the various options available rather than ask 
questions in an imaginary future context in which things that may be impossible 
are postulated to happen, and applications that do eventually come to fruition are 
missed. Nanotechnology was identified as the next new technology ripe for upstream 
engagement, wishing to avoid a repeat of the GM situation (Gavelin et  al. 2007). 
A series of different public engagements was conducted, but in retrospect, the sub-
ject ‘nanotechnology’ was too broad and had insufficient examples of applications to 
provide focus. The publics’ responses were broad generalities about preferred direc-
tions of research, which added little useful in the way of insights for policy makers 
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to guide the development. In contrast, an exercise by the EPSRC presented a set of 
clear potential medical applications of nanotechnology as future research themes, to 
which publics responded with some significant observations of factors which had 
been not considered by the scientists (Bhattachary et al. 2008).
Some research groups and institutes do indeed seek to engage people in their 
locality on their genome editing research. The need for a responsible innovation 
approach to genome editing has been recognised by research scientists, including the 
setting up of a European Steering Committee to address these issues (Chneiweiss 
et  al. 2017). In the UK, lay members are appointed to some scientific and ethical 
advisory committees, such as in the field of animal research, both at national and 
local level, where genome editing developments may be considered. In practice, it 
can be hard for a truly lay person to engage effectively with the wider implications 
of, say, a highly technical research proposal. A measure of understanding of the field 
is often needed, so that the ‘lay’ person becomes to some extent normalised to the 
alignment of the institution or research council, and no longer providing an entirely 
non-aligned viewpoint. Notwithstanding such involvement, in the main, publics 
have relatively little influence on the priorities and research plans of the institute, or 
interaction with the direction of research priorities set by the main funding agencies. 
This represents an Achilles heel in RRI, since scientists need to be answerable to 
their funders, but this tends to be done primarily at the level of review by the peers 
on funding committees.
At the level of exploratory research into genome editing, it might be argued that 
the scientific ‘genie’ is so far out of the bottle that any deliberative engagement with 
publics is already after the event. Engagement is certainly worth doing in terms of 
enabling the public to have the opportunity to know what is going on in areas of 
research which may impact on their lives, and whose funding may well have come 
from their taxes, but would have little influence on work that is already several years 
in progress.
We conclude that RRI is probably unrealistic when it comes to genome editing 
research, in that it would be to try to bring order to an avalanche, because of the 
unrestrained and chaotic way an exciting new field gets taken up by the research 
community. Only a few labs among many might be willing and able to do this sort of 
reflexive exercise and to adapt their research programmes and priorities accordingly.
Putting the ‘I’ Back into RRI
A more effective opportunity for applying the concept of RRI to genome editing 
could lie in the time lag between research which has reached ‘proof of principle’ 
stage in the idealised environment of the research laboratory, and the appearance of 
the refined and thoroughly tested product on the farm, the supermarket shelf or the 
clinic. There is a usually lengthy and expensive process of developing the conditions 
needed to commercialise a technique, achieving an adequate size of population, 
testing against adverse effects, and satisfying the relevant regulatory requirements. 
Often this can mean complex iterations rather than linear processes. To what extent 
does this provide an opportunity for engaging with a wider range of stakeholders 
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and publics before putting an application to be tested in the market, once there is a 
concrete product of the research which people could ‘get their heads round’? Given 
the difficulties noted about early upstream engagement on nanotechnologies, when 
there were few applications for the public to visualise, this would seem a more 
appropriate moment to apply the RRI concept to genome editing.
Such engagement by industry is not a new idea. For example, in 2000–2001 sev-
eral US biotechnology companies invited a range of stakeholders, including scepti-
cal NGOs, to a series of meetings to help them draw up an ethical code for geneti-
cally modified crop development, in the wake of mounting controversies, hosted by 
the Center for Bioethics of the University of Pennsylvania. One of the authors rep-
resented religious viewpoints in this exercise and also was the only European. The 
discussions addressed many of the facets of the complex problem, and were frank 
and open. It did not, however, result at that time in the hoped for industry code.
Fearing a hostile reception to nanotechnologies, the European Commission 
drew up a Nano Code which was largely aimed at research. A parallel initiative was 
launched by the Royal Society, the Nanotechnology Industries Association and other 
bodies to develop a Code for businesses working with nanotechnologies, organised 
Insight Investment, the Nanotechnology Industries Association and the Nanotech-
nology Knowledge Transfer Network. The resulting Responsible NanoCode was 
focused around seven principles that organisations should follow:4 
• Ensure that responsibility for guiding and managing its involvement with nano-
technologies resides with the Board or governing body;
• Proactively engage with its stakeholders and be responsive to their views in its 
development or use of products using nanotechnologies;
• Identify and minimise sources of risk for workers handling products using nano-
technologies, at all stages in the production process or in industrial use, to ensure 
high standards of occupational health and safety;
• Carry out thorough risk assessments and minimise any potential public health, 
safety and environmental risks relating to its products using nanotechnologies;
• Consider and respond to any social and ethical implications and impacts in the 
development or sale of products using nanotechnologies;
• Adopt responsible practice in the sales and marketing of products using nano-
technologies;
• Engage with suppliers and/or business partners to encourage and stimulate their 
adoption of the Code and so assure its own ability to fulfil its Code commit-
ments.
These were directed at the diverse fields of nanotechnologies, but a number of 
these principles could form guidance for the use of genome editing in industry. The 
second, fifth and sixth are of particular significance in the RRI aspects of relating to 
wider society.
4 http://www.nanot echia .org/sites /defau lt/files /files /20080 501_The%20Res ponsi ble%20Nan o%20Cod 
e%20Upd ate%20Ann oucem ent.pdf accessed 4/12/2018.
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In 2012, the UK Technology Strategy Board developed a Responsible Innovation 
Framework that focussed on reflecting the challenges faced by innovation down-
stream of research. Tait (2017) described its aims “to consider the very different 
issues faced in more downstream innovation processes, the different sets of actors 
and stakeholders that will need to be involved and the need to make decisions in 
timescales that reflect the real challenges faced by companies in a competitive eco-
nomic environment”.
The Responsible Innovation Framework intended to take account of the needs 
of industry innovators as well as societal expectations. Part of this addressed ele-
ments of company governance (the governance part of the ESG criteria—Environ-
mental, Social and Governance—for responsible companies, widely used in the field 
of corporate investment). This includes such factors as promoting sound practices 
in employment, avoiding undertaking business in countries that violate civil rights 
of their people etc. The project specific elements address the E and S criteria, for 
example promoting products that make a positive contribution to the environment 
and avoiding end uses that lead to social damage, and include the four EPSRC crite-
ria mentioned earlier.
Tait (2017) then developed this framework further into a suggested Consolidated 
Responsible Innovation Framework. In this framework, she focuses on four key ele-
ments; societal, environmental, business practice and regulation. The societal ele-
ment of this emphasises developing “products, processes and services designed to 
deliver societal benefits”, minimizing risks and supporting equitable distribution of 
risks and benefits, and avoiding deliberate harm. In this framework, some innova-
tions will require engagement but others will not. The environmental element sup-
ports the development of “products, processes and services that enhance and sup-
port the environment” and “considering lifecycle impacts including second and third 
order effects”. Tait critiques some current understandings of RRI for having insuf-
ficient consideration to the societal benefits that may be gained from innovation and 
that should be taken into account.
It is difficult to know how far industry has embedded such codes into its work-
ing ethos and strategies. Tait (2017) suggests that industry actors were reluctant to 
engage with this attempt to developing a RRI framework due to perceptions of such 
processes politicising innovation initiatives in unhelpful ways. It may be the case 
that a company fears to do this in case it ‘opens up a can of worms’, attracting nega-
tive publicity, jeopardising their share price or their ability to win venture capital. 
This may be counterproductive, however. A House of Lords report on nanotechnolo-
gies applied to food noted the secrecy of companies to acknowledge the use of nano-
technologies in their food products (for fear of a negative public reaction if they did 
so), concluding that hiding something was more likely to precipitate negative reac-
tion than being transparent (House of Lords 2010).
But for a company to introduce some form of RRI exercise into its strategy could 
pose a number of problems. First, at what point in the transition period should RRI 
be done, once the decision has been made to take it out of the lab and embark on 
the process leading to its ultimate production? Secondly, if the feedback from an 
RRI exercise turned out to be negative, is the company prepared to change what it 
intended to do, and accept some loss of its sunk costs of research?
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Thirdly, there are the prevailing values and power relations within the company at 
that point in time, perhaps coming down less to company values than to influential 
individuals in the management or board. Some could argue that RRI was exercising 
‘due diligence’ in foresighting the likely market success of the projected product, to 
circumvent the risk that, if ‘the market’ was unprepared or potentially hostile, the 
whole project might founder. On the other hand, others might see RRI as introduc-
ing an element of uncertainty and delay into the trajectory of commercialisation, 
if the dominant voice in the company is the urgency to see the innovation come to 
market and secure a place among possible rivals, and to pay back some of the invest-
ment. In the latter view, the risk would be that a less fastidious company, or perhaps 
one working in a less regulated country, could corner the market in the meantime.
The assertion that there was no time to find out how a controversial product fitted 
with wider society would seem incompatible with responsible innovation. It might 
rather be argued that the time it might take to get the answer ‘yes, go ahead with 
society’s blessing’ was an integral part of the process of translation, from which the 
organisation could go ahead with more confidence. An established plc with a port-
folio of products should be able to cope with this process, but a venture capitalised 
start-up company with known rivals in the field, for which this is the only product, 
delay might be perceived as unacceptable.
Meijboom et al. (2006) identified a need for what they termed ‘pro-active respon-
sibility’, in which the exercise of responsibility in innovation moves from something 
that is done because it is enforced externally, such as regulation, to an inner respon-
sibility, expressing the person’s or the company’s own values and visions of a desir-
able future. In making this change, it then becomes important to make explicit the 
values that are driving a specific development. This in turn implies a need to be 
prepared to engage with and be responsive to other values.
The likelihood that a company embraces the concept of RRI is likely to depend 
on both internal and external factors. The level of uptake depends on the values and 
self-image of the company, and the prevailing internal reasons which influence why 
it behaves in particular ways. Key external factors are the degree of competition and 
the confidence that consumers would buy the product. This last point is particularly 
important for genome editing in food animals, because consumer acceptance in 
Europe is uncertain. Any company wishing to have a European market for the types 
of innovations highlighted in the previous section will need to take RRI seriously on 
board.
Applying RRI to Genome Editing
We now return to the two examples of animal genome editing cited in “Genome 
Editing in Livestock Animals” section above. These were chosen, not only because 
they are relatively close to market, but also in that they address livestock welfare 
issues in a production context. This, in part, is a conscious response to the wide-
spread criticism of most genetically modified food crops, that they provided produc-
tion advantages to farmers, but no tangible benefits to sceptical consumers.
1 3
Genome Editing and Responsible Innovation, Can They Be…
It remains to be seen, however, whether gene edited polled dairy cattle and PRRS 
resistant pigs will be viewed by veterinary surgeons and farmers as another method 
of producing the animals in more sustainable and welfare friendly ways, and whether 
consumers and retailers view the food products as acceptable. These practical cases 
are examples where RRI could play an important role. We now consider some of the 
pertinent issues which the application of RRI would need to address.
Example 1: Polled Dairy Cattle
It could be argued that this is a minor, even trivial, change to the physiology of the 
animal, with considerable welfare benefits. However, there is evidence to suggest 
that horns also have a role in thermoregulation and in self-grooming (Knierim et al. 
2015).
The stated welfare motivation is that cows without horns can do less damage to 
each other and to their human carers. There appears to be conflicting evidence as to 
whether cows without horns are less aggressive than those with horns; those with 
horns appear to keep greater distances from each other (Knierim et al. 2015). The 
specific circumstances may also be important in identifying behavioural changes, 
e.g. whether the cows are housed or grazing, different effects on high ranking or 
low ranking cows, or young cows newly being introduced into the herd (Knierim 
et al. 2015). All these questions will arise whether the cows are polled as a result of 
genome editing, by physical removal of horns or natural polledness, but they serve 
to indicate the complexity of an issue which at first glance may appear simple.
The second welfare aspect is that concerns are raised about the methods used in 
current agricultural practice to remove their horns when they are calves. These usu-
ally involve cauterization or applications of caustic paste (Spurlock et al. 2014), pro-
cesses that are both painful for the animals and unpleasant for the human operators 
of the process. Nonetheless, Cozzi et al. (2015) report that the practice is very com-
mon among dairy cattle in EU Member States, with 81% of the surveyed dairy farms 
using animals where horns have been removed. They found the practice is more 
common when cattle are loose housed rather than tethered. Ironically, an increased 
removal of horns may be a consequence of changing dairy production systems to 
improve welfare, by replacing tethering cows individually to loose housing, allowing 
them freedom of movement.
If polled dairy cows are a desirable aspiration, genome editing is only one of sev-
eral ways of achieving this end, including selecting polled cows, cross-breeding, and 
using genetic markers to aid selection. Selecting polled cows for the next generation 
requires these animals to exist in order to be selected for the next generation. Polled 
dairy cows are rare and selection for these animals may compromise selection for 
other desirable characteristics. The extent to which other desirable traits are affected 
may vary with breed, for example Spurlock et al. (2014) calculated larger negative 
impacts for Holstein cattle than Jersey cattle.
Cross-breeding polled beef cattle with horned dairy cattle is possible, but mixing 
beef genes into dairy would have a severe impact on important characteristics such 
as milk yield. The process of breeding would also be slow because the polled variant 
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is a recessive gene; both parents must carry it before the offspring are polled. Using 
genetic tests to identify cattle with the polled gene variant exist, for example in Aus-
tralia,5 but a given genetic marker appears only to apply to some breeds but not oth-
ers. The genetics of polledness appears to be more complex than previously thought 
(e.g. Wiedermar et al. 2014; Chen et al. 2017).
Based on the previous responses of public, media and retailers to GM foods in the 
late 1990s, the new application of genome editing to food animals could be seen as 
a potentially contentious area in the UK and the rest of Europe. From the industry 
point of view, in this example no transfer of genes across species is involved. All 
that has been done is to introduce a gene variant from one breed of cattle to another. 
Would the fact that it is not strictly transgenesis be a clinching argument for con-
sumer acceptance, or would any genetic change be considered in the same vein as 
GM, in the sense of ‘fiddling around with genes’? Would a major retailer fear being 
targeted by aggressive NGO action if it ‘stepped out of line’ and became the first to 
market the dairy products of gene edited polled cattle?
Moreover, the arguments made above of the human and animal welfare benefits of 
polledness from an industry and production perspective may not be readily accepted 
by publics. While these may be obvious to those familiar with current agricultural 
practice, to most people outside it the practice of polling could come as a surprise, 
because of a general low level of public knowledge of current UK agricultural prac-
tices in general, and in this case the reality of working with livestock. Thus the offer 
of a ‘technical fix’ to an existing industry problem may appear less appealing than 
questioning polling altogether. For example, a perception that ‘if cows have horns, 
it is unnatural or inhumane to remove them’ might be significant. Another reaction 
of lay publics might be that an ‘industrialised’ dairy production system is unaccep-
table, and turn instead to non-dairy sources of ‘milk’ based around plant products. 
Last, but by no means least, is that for some people the overriding question is one of 
ethical principle, namely that it is considered unacceptable to use animals for food, 
or even for any human purposes at all.
There may therefore be quite different views on the acceptability of a genome 
editing application even motivated by welfare considerations. It would be impor-
tant therefore to engage wider society in an RRI exercise, to bring out and discuss 
some of these issues. This might serve to bridge some of the gap between agricul-
tural practice and the consumer, which might result in changes of both attitude and 
practice on either side. The fear on the part of industry of doing so should be set 
against the risk of a polarised and sensationalised confrontation via the media, like 
that which characterised much of the UK GM food debate.
5 https ://www.goodm eat.com.au/globa lasse ts/goodm eat/anima l-healt h-and-welfa re/poll-gene-test.pdf 
accessed 1/12/18. However, the web page appears to date to 2013 and it is not clear as to the extent to 
which the markers are used in current practice.
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Example 2: PRRS Resistance in Pigs
The application of genome editing to introduce resistance to PRRS infection is 
argued by its proponents to be attractive from animal health and welfare perspec-
tives, as well as from and economic point of view. How would this be received by 
publics?
In contrast to the polled cattle example, the welfare benefit of preventing pigs 
from contracting PRRS is less likely to be contested, as such, even though most peo-
ple would be unlikely to have heard of the disease. If one accepts eating pig products 
at all, disease prevention would be seen as a humane response if we had the means 
to do so, but some might still be uncomfortable with the method. Would people eat 
pork from such pigs? Would the welfare of pigs weigh more in consumers’ minds 
and hearts than the associations of genetic modification of their food? Would this be 
a breakthrough, in that here was an example of genetically altered food for a purpose 
that was seen as valid, or would the demand be for alternative solutions because of 
the pervasive stigma of GM, even though once again transgenesis is not involved.
Once again, an appropriate RRI engagement between the industry, stakeholders 
and publics could offer the hope of a more informed assessment on the part of UK 
citizens. For example, at first sight some might dismiss this application as a techni-
cal fix for a problem that is caused by large scale and intensive pig units. But discus-
sion with industry could reveal a more nuanced understanding, that while large scale 
pig production may exacerbate the spread of PRRS, it would not eliminate a disease 
that is a potential threat to all types of pig unit, large and small, indoor and outdoor, 
etc. Again engagement might also widen the debate to include other factors, such as 
the tendency for the PRRS infection also to affect the pig’s disease defence mecha-
nism. This makes the pig more susceptible to other diseases, such as pneumonia,6 
that are then treated with antibiotics. In an era where bacterial resistance to antibiot-
ics has become a major policy concern, and reducing the use of antibiotics in food 
production a priority, avoiding these secondary infections becomes important. Thus 
what started out perhaps as a single question may encourage a reflection on wider 
issues.
What Do These Examples Tell Us About RRI?
A major underlying problem is the knowledge gap between the food we eat and the 
way it is produced. Whereas polled cattle are seen by the cognoscenti in the indus-
try as a significant animal welfare improvement, and resistance to PRRS as highly 
desirable within the pig industry, there is a disconnection of such applications from 
wider society. Whether some of these are perceived to be welfare benefits by wider 
publics remain to be seen. Well-meaning applications of genome editing could fall 
foul of this disconnect. This may be a more serious issue than the potential impact 
6 http://www.thepi gsite .com/disea seinf o/97/porci ne-repro ducti ve-respi rator y-syndr ome-prrs/acces sed 
1/12/18.
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of adding genome editing technology itself. Without some form of RRI engagement, 
the focus on benefits that do not impact immediately on consumers may still not be 
solved.
One example of a thoughtful method of public engagement (Gremmen and Block 
2016) was reported at the Eursafe meeting in 2017. Here, publics were asked to 
engage with a range of different methods of dealing with male chicks of egg laying 
strains. As the male chicks currently have no value in food production, the current 
practice is to kill them at hatching. A sample of Dutch publics were invited to com-
ment on a range of alternative methods of removing male chick, including taking 
biopsies to identify male eggs and using genome editing to produce green fluores-
cence in male eggs which could then be removed before hatching. In this small sam-
ple, the public preferred genome editing to biopsies, but found the current method 
of killing make chicks at birth the most preferable. While too much should not be 
made of a limited example, it illustrates the ability of those publics to engage with a 
difficult aspect of egg production and to weigh up alternative management methods.
Some evidence of the types of genome editing applications which might elicit 
a positive public response can be gleaned from an exercise conducted by Hopkins 
Van Mil on behalf of the UK Royal Society (Van Mil et al. 2017). Applications for 
reduced antibiotic use, greenhouse gas emissions, and reduced possibility of trans-
mitting zoonotic diseases were all deemed acceptable. Concern for the environment 
and animal welfare were important, and use of genome editing for increasing pro-
ductivity was rejected. Specialist uses such as preventing the extinction of a species 
or producing milk suitable for babies were affirmed. A major pre-occupation was 
to ensure genome editing was used to address inequality (in all its manifestations). 
Therefore, questions were raised about who owns the technology, who gets rich 
from its use and can it be used to unfairly obtain monopoly power?
This specific dialogue process could be interpreted as giving a rather positive 
response to applications of genome editing, given some caveats. However, history 
reminds us that in the early stages of development of GM crops, the UK Biotech-
nology and Biological Sciences Research Council (BBSRC) held a public consen-
sus conference. This conference produced similar responses, i.e.  no in-principle 
objections, but highlighting the need for certain aspects to be paid attention to e.g. 
the impact on Lower Income Countries (Purdue 1999). What might be the lesson 
from this earlier exercise, apart from the fact that the results appear to have been 
ignored by policy makers? Does this suggest that it is too early to take the Royal 
Society results at face value, and that care needs to be taken in development? A 
further caveat about RRI engagement comes, ironically, from the field of regulation 
and law. The European Court of Justice was asked by a French farmers’ organisation 
to judge on whether an application of genome editing should fall within the scope 
of the existing EU Directive on genetically modified organisms (Directive 2001/18/
EC). One of the crucial arguments was whether genome editing resembled a more 
precise form of the crop modifications made by random mutagenesis, which fell out-
side the Directive. To the incredulity of many scientists, the court judged that these 
genome edited organisms were to be considered as subject to the full range of test-
ing and regulation according to the EC Directive, as if they were transgenic, but that 
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the early untested products of random mutagenesis were de facto considered to have 
been immune from such risks.
The problem for RRI is less the judgement and its implications, than the fact that 
this consideration was made without an engagement with publics. The decision by 
the European Court of Justice on effectively side-stepped any processes of wider 
societal engagement. Has this reduced RRI of genome editing in food into a matter 
of legal judgement, which is as far removed from the public as decisions over GM 
food were in the mid-1990s?
To those keen to press ahead with a new technology, the regulatory process can 
represent a delay in the innovation process. But done properly, regulation represents 
the formal statutory public responsibility of a new technology, and its governance. 
Regulation sets bounds to what can be done, who can do it and under what condi-
tions can things be done. But if there has been no discussion with the public, this 
could be argued to be a case where regulation has been socially premature, and not 
done on behalf of the society.
Conclusions
In this paper we have explored the tensions between rapidity of genome editing 
research and the slower, more reflective pace required to undertake effective RRI 
processes. In particular, we have examined the prospects of extending the RRI 
framework from the research arena, to industry and the commercialisation of the 
outputs of genome editing.
We have briefly reviewed the principal features of RRI, with four core principles 
of anticipation, reflexivity, inclusion and responsiveness. It was noted that in an EU 
and UK context, RRI is mainly considered in relation to research, and less to appli-
cation in innovation. We then summarised the disruptive advent of genome editing 
techniques and especially of the CRISPR method, whose ease of use, cheapness, 
specificity and efficiency have led to an avalanche of applications in a wide range of 
fields. Notable amongst these is making direct genetic changes to food animals for 
the first time, in cattle and pigs. In contrast to ‘conventional’ genetic modification, 
most of these are focussing on traits that do not require transfer of genes from one 
species to another, and are deemed to provide welfare benefits to the animals.
We suggest that the speed, the breadth of scope and the disruptive potential of 
genome editing together present a serious challenge to the very concept of responsi-
ble research and innovation, because to engage with publics and other stakeholders 
on novel and disruptive technologies takes time. Moreover, engagement exercises 
only reach a small number of people. Mass media and social media have much wider 
impact, but may then be subject to the tropes and biases of these media, resulting 
in less well informed and reflexive public debate. In the case of nanotechnologies 
engagements were too early and the questions are too broad. In the case of CRISPR 
research the ‘genie’ might well be out of the bottle.
We suggest that it is in the application stage of genome editing that RRI has a 
crucial role to perform. This would entail putting the ‘I’ back into the RR, and focus 
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on encouraging companies to take RRI on board. A number of examples are cited 
including the UK Technology Strategy Board’s Responsible Innovation Framework.
We applied RRI thinking to our two example applications of genome editing to 
livestock and highlighted some of the main issues which would need to be taken into 
account. We found that a key aspect is the knowledge gap of publics of current prac-
tices in livestock agriculture, which could lead to unexpected outcomes from public 
consultations. RRI has an important role therefore not only in considering the inno-
vation but understanding it in the context of current agricultural processes. A useful 
way of examining such questions is to consider the range of options that could be 
available to address the issue, rather than just the innovation under question. Fur-
thermore, as applications of biotechnology are subject to regulations, it may be the 
case that the final arbiter is the legal profession. This has effectively been the case 
in the EU due to the judicial review asserting that genome edited products should 
be treated under GMO legislation, making it unlikely that they will be economic to 
develop.
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